| 货号 |
中文名 |
英文名 |
品牌 |
规格 |
价格 |
详细 |
| V204-100mg |
Anti-Human α4β7 integrin (Vedolizumab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100 mg |
68310 |
More |
| V204-25mg |
Anti-Human α4β7 integrin (Vedolizumab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25 mg |
27255 |
More |
| V204-50mg |
Anti-Human α4β7 integrin (Vedolizumab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50 mg |
48300 |
More |
| V204-5mg |
Anti-Human α4β7 integrin (Vedolizumab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5 mg |
7590 |
More |
| V205-500μg |
Anti-Human α4β7 integrin (Vedolizumab) – Fc Muted? - 500 μg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500 μg |
5451 |
More |
| V210-1.0mg |
Anti-Human VEGF-A (Brolucizumab) - 1.0 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0 mg |
2001 |
More |
| V210-100mg |
Anti-Human VEGF-A (Brolucizumab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100 mg |
68310 |
More |
| V210-25mg |
Anti-Human VEGF-A (Brolucizumab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25 mg |
27255 |
More |
| V210-50mg |
Anti-Human VEGF-A (Brolucizumab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50 mg |
48300 |
More |
| V210-5mg |
Anti-Human VEGF-A (Brolucizumab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5 mg |
7590 |
More |
| V273-100mg |
Anti-Mouse CD309 (VEGFR2) - Purified in vivo PLATINUM? Functional Grade Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100mg |
44800 |
More |
| V273-1mg |
Anti-Mouse CD309 (VEGFR2) - Purified in vivo PLATINUM? Functional Grade Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1mg |
3360 |
More |
| V273-25mg |
Anti-Mouse CD309 (VEGFR2) - Purified in vivo PLATINUM? Functional Grade Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25mg |
21000 |
More |
| V273-50mg |
Anti-Mouse CD309 (VEGFR2) - Purified in vivo PLATINUM? Functional Grade Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50mg |
32200 |
More |
| V273-5mg |
Anti-Mouse CD309 (VEGFR2) - Purified in vivo PLATINUM? Functional Grade Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5mg |
6370 |
More |
| V30-1.0mg |
Anti-Human von Willebrand factor (vWF) (Caplacizumab) - 1.0 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0 mg |
2001 |
More |
| V30-100mg |
Anti-Human von Willebrand factor (vWF) (Caplacizumab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100 mg |
68310 |
More |
| V30-25mg |
Anti-Human von Willebrand factor (vWF) (Caplacizumab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25 mg |
27255 |
More |
| V30-50mg |
Anti-Human von Willebrand factor (vWF) (Caplacizumab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50 mg |
48300 |
More |
| V30-5mg |
Anti-Human von Willebrand factor (vWF) (Caplacizumab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5 mg |
7590 |
More |
| W100-1.0 L |
UltraWash? - Tris 10X Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0L |
4261 |
More |
| W100-100 ml |
UltraWash? - Tris 10X Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100ml |
1071 |
More |
| W101-1.0 L |
UltraWash? - PBS 10X Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0L |
4152 |
More |
| W101-100 ml |
UltraWash? - PBS 10X Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100ml |
983 |
More |
| W105-50 μg |
Recombinant Human WISP-1 Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
10051 |
More |
| W106-20 μg |
Recombinant Human WISP-2 Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
6354 |
More |
| W106-5 μg |
Recombinant Human WISP-2 Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5μg |
3910 |
More |
| W107-20 μg |
Recombinant Human WISP-3 Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
7582 |
More |
| W142-0.1 mg |
Anti-West Nile Virus Core (CT) (WNV Core) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
8602 |
More |
| W142-20ug |
Anti-West Nile Virus Core (CT) (WNV Core) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
1857 |
More |
| W143-0.1 mg |
Anti-West Nile Virus Core (NT) (WNV Core) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
8602 |
More |
| W143-20ug |
Anti-West Nile Virus Core (NT) (WNV Core) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
1857 |
More |
| W144-0.1 mg |
Anti-West Nile Virus Envelope Protein (CT) (WNV Env) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
8602 |
More |
| W144-20ug |
Anti-West Nile Virus Envelope Protein (CT) (WNV Env) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
1857 |
More |
| W145-0.1 mg |
Anti-West Nile Virus Envelope Protein (NT) (WNV Env) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
8602 |
More |
| W145-20ug |
Anti-West Nile Virus Envelope Protein (NT) (WNV Env) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
1857 |
More |
| W146-0.1 mg |
Anti-West Nile Virus Envelope Protein (Intermediate Domain) (WNV Env) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
8602 |
More |
| W146-20ug |
Anti-West Nile Virus Envelope Protein (Intermediate Domain) (WNV Env) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
1857 |
More |
| W147-0.1 mg |
Anti-West Nile Virus Matrix (CT) (WNV Matrix) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
7761 |
More |
| W147-20ug |
Anti-West Nile Virus Matrix (CT) (WNV Matrix) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
3812 |
More |
| W148-0.1 mg |
Anti-West Nile Virus Matrix (Intermediate Domain) (WNV Matrix) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
8602 |
More |
| W148-20ug |
Anti-West Nile Virus Matrix (Intermediate Domain) (WNV Matrix) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
1857 |
More |
| W149-50 μg |
West Nile Virus Core (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
| W150-50 μg |
West Nile Virus Core (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
| W151-50 μg |
West Nile Virus Envelope Protein (Intermediate Domain) Blocking Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
| W152-50 μg |
West Nile Virus Envelope Protein (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
| W153-50 μg |
West Nile Virus Envelope Protein (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
| W154-50 μg |
West Nile Virus Matrix (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
| W155-50 μg |
West Nile Virus Matrix (Intermediate Domain) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
| W157-100 μg |
Anti-Human WISP-1 Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
11580 |
More |
